NUDT15 and acute lymphoblastic leukemia: For a comprehensive evaluation of all PGx interactions among NUDT15, TPMT, IL6, and CRIM1, we performed comprehensive ROC analysis using data of all 320 pediatric patients with ALL (Fig. 5).